Royal DSM is a global science-based company (with >22.000 employees) active in health, nutrition and materials. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.

DSM is making use of bio-based feedstocks and bio-based technologies (fermentation / enzymes) for a range of products in food, feed, nutrition, anti-infectives, pharma and materials. DSM is pioneering advances in renewable energies such as cellulosic bio-ethanol and in renewable building blocks like bio-based succinic acid.

DSM’s strategy is to license its technology and expertise to bio-based entrepreneurs, enabling them to convert biomass in a commercially viable and sustainable way.

DSM has a joint venture with POET, an American renewable fuel pioneer, to commercially demonstrate and license cellulosic bio-ethanol derived from corn crop residue (biomass) by way of a biological process using enzymatic hydrolysis followed by fermentation. DSM and the French starch manufacturing company Roquette have a joint venture agreement, named Reverdia, for the production, commercialization and market development of Biosuccinium™, sustainable succinic acid in Europe.